Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Taxotere approved in eight countries for two indications

July 12, 1996

Yoshitomi and Yamasa Shoyu out-license DMDC

July 12, 1996

Vertex begins phase II study of VX-710

July 5, 1996

Somatix gene therapy receives patent coverage

July 5, 1996

Kyowa Hakko isolates antitumor/antibacterial compound from Streptomyces

July 5, 1996

Johns Hopkins researches HIC-1-associated tumor

July 5, 1996

Zeneca reveals antiproliferative aniline derivatives

July 5, 1996

Halistatin 3: Antineoplastic agent of marine origin

July 5, 1996

Cytotoxic compound eleutherobin reported by University of California

July 5, 1996

Glaxo Wellcome describes antitumor antibody conjugates

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
Research grants support early clinical trials of ALS treatments
BioWorld Science
The ALS Association has announced the recipients of its 2025 Hoffman ALS Clinical Trial Awards. These research grants, worth up to $1 million each, support...